References
- Krause C, Korchynskyi O, de Rooij KD, et al. Distinct modes of inhibition by sclerostin on bone morphogenetic protein and Wnt signaling pathways. J Biol Chem. 2010;285(53):41614–41626.
- ten Dijke PT, Krause C, de Gorter DJ, et al. Osteocyte-derived sclerostin inhibits bone formation: its role in bone morphogenetic protein and Wnt signaling. J Bone Joint Surg Am. 2008;90(Suppl 1):31–35.
- Van Wesenbeeck LV, Cleiren E, Gram J, et al. Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density. Am J Hum Genet. 2003;72(3):763–771.
- Silverman SL. Sclerostin. J Osteoporos. 2010;2010:941419.
- García-Martín A, Rozas-Moreno P, Reyes-García R, et al. Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2012;97(1):234–241.
- Urano T, Shiraki M, Ouchi Y, et al. Association of circulating sclerostin levels with fat mass and metabolic disease–related markers in Japanese postmenopausal women. J Clin Endocrinol Metab. 2012;97(8):E1473–E1477.
- Morales-Santana S, García-Fontana B, García-Martín A, et al. Atherosclerotic disease in type 2 diabetes is associated with an increase in sclerostin levels. Diabetes Care. 2013;36(6):1667–1674.
- Namgung R, Tsang RC. Bone in the pregnant mother and newborn at birth. Clin Chim Acta. 2003;333:1–11. Review.
- Dorota DK, Bogdan KG, Mieczyslaw G, et al. The concentrations of markers of bone turnover in normal pregnancy and preeclampsia. Hypertens Pregnancy. 2012;31(1):166–176.
- Barker DJ. The developmental origins of adult disease. J Am Coll Nutr. 2004;23(6 Suppl):588S–595S.
- Curhan GC, Willett WC, Rimm EB, et al. Birth weight and adult hypertension, diabetes mellitus, and obesity in US men. Circulation. 1996;94(12):3246–3250.
- Gardosi J, Mongelli M, Wilcox M, et al. An adjustable fetal weight standard. Ultrasound Obstet Gynecol. 1995;6(3):168–174.
- Kurmanavicius J, Florio I, Wisser J, et al. Reference resistance indices of the umbilical, fetal middle cerebral and uterine arteries at 24–42 weeks of gestation. Ultrasound Obstet Gynecol. 1997;10(2):112–120.
- Chamberlain PF, Manning FA, Morrison I, et al. Ultrasound evaluation of amniotic fluid volume. I. The relationship of marginal and decreased amniotic fluid volumes to perinatal outcome. Am J Obstet Gynecol. 1984;150(3):245–249.
- Burkhardt T, Schäffer L, Schneider C, et al. Reference values for the weight of freshly delivered term placentas and for placental weight-birth weight ratios. Eur J Obstet Gynecol Reprod Biol. 2006;128(1–2):248–252.
- American College of Obstetricians and Gynecologists. ACOG Committee. ACOG Committee opinion no. 548: Weight gain during pregnancy. Obstet Gynecol. 2013;121(1):210–212.
- Wild J, Pateisky P, Küssel L, et al. Preeclampsia – a risk factor for osteoporosis? Analysis of maternal sclerostin levels and markers of bone turnover in patients with pre-eclampsia. Hypertens Pregnancy. 2014;33(3):333–340.
- Platz M, Stepan H, Schrey S, et al. Serum levels of sclerostin in cardiometabolic disorders during pregnancy. Cytokine. 2015;76(2):591–593.
- Godang K, Frøslie KF, Henriksen T, et al. Umbilical cord levels of sclerostin, placental weight, and birth weight are predictors of total bone mineral content in neonates. Eur J Endocrinol. 2013;168(3):371–378.
- Coulson J, Bagley L, Barnouin Y, et al. Circulating levels of dickkopf-1, osteoprotegerin and sclerostin are higher in old compared with young men and women and positively associated with whole-body bone mineral density in older adults. Osteoporos Int. 2017;28(9):2683–2689.
- Yamamoto M, Yamauchi M, Sugimoto T. Elevated sclerostin levels are associated with vertebral fractures in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2013;98(10):4030–4037.
- Yamamoto M. Insights into bone fragility in diabetes: the crucial role of bone quality on skeletal strength. Endocr J. 2015;62(4):299–308.
- Montagnani A, Gonnelli S, Alessandri M, et al. Osteoporosis and risk of fracture in patients with diabetes: an update. Aging Clin Exp Res. 2011;23(2):84–90.